16
Jun 2026
Naloxone provides life-saving tool to reverse opioid overdoses
Anyone can save a life during an opioid overdose with naloxone, a front-line defense in the nation's overdose crisis.
16
Jun 2026
Anyone can save a life during an opioid overdose with naloxone, a front-line defense in the nation's overdose crisis.
16
Jun 2026
After identifying significant differences in stroke care and outcomes for patients on different Medicare plans, a UVA Health doctor is launching an ambitious effort to better understand the sources of those differences and ensure patients get the best care possible.
16
Jun 2026
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying promising compounds that could eventually become new therapies.
16
Jun 2026
Announcing a new article publication in BIO Integration. Insulin resistance (IR) and chronic kidney disease (CKD) are independent risk factors for cardiovascular disease (CVD).
16
Jun 2026
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become massively popular for weight loss, but results vary from person to person and drug to drug.
16
Jun 2026
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become massively popular for weight loss, but results vary from person to person and drug to drug.
16
Jun 2026
Unlike cigarettes or alcohol, cannabis products often come packaged as colorful gummies, chocolates, candies and snacks that can look remarkably similar to items found in a grocery store aisle.
16
Jun 2026
Unlike cigarettes or alcohol, cannabis products often come packaged as colorful gummies, chocolates, candies and snacks that can look remarkably similar to items found in a grocery store aisle.
16
Jun 2026
It's a mystery. The eye disease known as retinopathy of prematurity (ROP) can make infants permanently blind if they are not treated. But there are big differences between how often Norwegian hospitals actually provide this treatment.
16
Jun 2026
A study conducted at the University of Jyväskylä, Finland, was the first to investigate the effects of prebiotic xylo-oligosaccharides (XOS) on fatty liver in humans.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more